CRNX:NASDAQ
Crinetics Pharmaceuticals
$84.95
0.00%
(0.00) 1D
Aug 31, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Vertex Pharmaceuticals Maps Growth Beyond CF at Cantor Conference
Profile
Crinetics Pharmaceuticals was a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.
In July 2026, Vertex Pharmaceuticals agreed to acquire the company for $10 billion. The acquisition closed in September of 2026. Wikipedia